Cavernous Sinus Syndromes

Updated: Oct 24, 2024
  • Author: Ryszard M Pluta, MD, PhD; Chief Editor: Robert A Egan, MD  more...
  • Print
Overview

Overview

Cavernous sinus syndrome describes symptoms comprising ophthalmoplegia, chemosis, proptosis, Horner syndrome, and/or trigeminal sensory loss evoked by vascular, inflammatory, traumatic, congenital, or neoplastic processes affecting the cavernous sinus near the midline of the frontotemporal part at the base of the skull. Numerous diseases evoke cavernous sinus syndrome. The most often reported are intra and extracavernous or metastatic neoplasms, intracavernous carotid artery aneurysms, carotid-cavernous fistulas (see image below), infections, thrombosis, and Tolosa-Hunt syndrome.

Carotid-cavernous fistula. Carotid-cavernous fistula.

Pathophysiology

The cavernous sinuses are interconnected, multi-channeled venous structures on both sides of the sella turcica (ST; see image below) with the pituitary gland inside (PG). The cavernous sinus extends from the orbital apex to the Meckel cave. Each sinus consists of venous channels bordered by dura matter and collects blood from the superior and inferior orbital veins, pterygoid plexus, and the Sylvian vein draining into the superior and inferior petrosal sinuses. Inside the cavernous sinus, there is an intra-cavernous part of the carotid artery (ICA) with its sympathetic plexus (SP). Within the lateral wall, there are cranial nerves III (oculomotor), IV (trochlear), V1 (ophthalmic branch of trigeminal nerve), and V2 (maxillary branch of trigeminal nerve); the VI nerve (abducens) is in the vicinity of the internal carotid artery (see image below). The presence of those cranial nerves within the cavernous sinus is responsible for characteristic cavernous sinus syndrome symptoms of partial or complete ophthalmoplegia and facial sensory losses, which can be accompanied by facial pain and exophthalmos.

The figure depicts the frontal view of structures The figure depicts the frontal view of structures in the vicinity of the left cavernous sinus; details are in the text. PG-pituitary gland, ST-sella turcica, ICA-internal carotid artery, SP-sympathetic plexus, III-VI, cranial nerves. Courtesy of Akimichka.

Cavernous sinus neoplasms

Cavernous sinus tumors are the most common cause of cavernous sinus syndrome. Tumors may be primary or arise as either local spread or metastases. Examples of primary tumors include schwannoma, plexiform neurofibroma, malignant peripheral nerve sheath tumor, cavernous hemangioma, meningioma, melanocystoma, chondroma, and chondrosarcoma. Examples of locally spreading tumors are nasopharyngeal carcinoma, pituitary adenoma, chordoma, epidermoid, and dermoid cysts. Metastatic lesions are most often from the breast, prostate, or lung. Total resection of these lesions remains challenging and, in many cases, impossible if the lesion is invasive. [1] Other treatment solutions include radiotherapy, which often offers transient relief, particularly in nasopharyngeal cancer. Lateral extension of pituitary tumors may be treated with surgical resection and dopamine agonists in the case of prolactinoma. [1, 2]  

Cavernous sinus aneurysms

Unlike intracranial aneurysms in the extradural locations, carotid-cavernous aneurysms do not involve a major risk of subarachnoid hemorrhage but are often giant (> 2.5 cm in diameter). Thus they produce symptoms through compression of the adjacent structures and their rupture can result in direct carotid-cavernous fistulas (CCFs). These aneurysms, which are more frequent in the elderly, often present with indolent ophthalmoplegia. Although some patients suffer minor disability and do not require treatment, endovascular coiling is often successful and is attempted in many patients. [3, 2]

Carotid-cavernous fistulas

Carotid-cavernous fistula (CCF) is an abnormal connection between the carotid artery and the sinus. There are two main types of CCF. Direct fistula (type A) is characterized by a high blood flow communication between the carotid artery and cavernous sinus. It manifests with a sudden onset of pulsating exophthalmos, proptosis, chemosis, visual loss, and usually painful ophthalmoplegia (image above). Trauma or aneurysm rupture is a common cause of a direct carotid-cavernous fistula. Dural (indirect) fistula (types B–D) occurs when communication develops between the cavernous sinus and the meningeal or persistent fetal branches of the internal carotid artery, external carotid artery, or both. Indirect fistula is usually caused by nontraumatic conditions such as hypertension, fibromuscular dysplasia, type IV Ehlers-Danlos, and internal carotid artery dissection. [4] This type has a milder and more insidious presentation than a direct fistula, often with spontaneous resolution.  

Interventional radiologists can successfully treat all fistula types with endovascular occlusion techniques. Occasionally, surgical treatment with carotid ligation is necessary; this is sometimes preceded by a superficial temporal-to-middle cerebral bypass to ensure cerebral circulation after carotid ligation. [2]

Cavernous sinus inflammatory, infectious, and granulomatous lesions

Infection within the cavernous sinus or adjacent structures can result in sinus thrombosis and/or the development of inflammatory changes. The rare but important causes include aspergillosis, Wegener granulomatosis, tuberculosis, and sarcoidosis. Some share symptoms with Tolosa-Hunt syndrome (unilateral ophthalmoplegia, cranial nerve palsies, and a dramatic response to corticosteroids), which describes a retroorbital pseudotumor encroaching the cavernous sinus. [2]

Epidemiology

Frequency

In the United States, approximately 5% of ophthalmoplegias are secondary to the involvement of cranial nerves in the cavernous sinuses. This is probably true worldwide. 

Cavernous sinus aneurysms represent 5% of giant intracranial aneurysms. [2]

Mortality/Morbidity

Most of the lesions affecting the cavernous sinuses are treatable.

Metastatic cancer is a frequent cause of cavernous sinus syndromes, and the prognosis depends on the specific tumor type.

Cavernous sinus septic thrombophlebitis mortality has decreased from 100% to 20% with the improvement of diagnosis and therapies. 

Cavernous sinus aneurysms and CCFs can be treated successfully by endovascular techniques.

The lateral extension of pituitary tumors, a common cause of this syndrome, can be treated by surgical resection, radiation therapy in selected patients, and a dopamine agonist in the case of prolactinoma. 

Clinical Presentation

History

The signs and symptoms frequently found in patients with cavernous sinus lesions include visual loss, proptosis, ocular and conjunctival congestion, elevation of ocular pressure, ophthalmoplegia, and pain. Various combinations of these symptoms may occur, which generally are unilateral but may be bilateral with neoplastic processes. Symptoms may be acute or slowly progressive. Primary tumors are the most frequent neoplasm responsible for cavernous sinus syndrome.

Cavernous sinus tumors 

Acute or slowly progressive ophthalmoplegia is the dominant presentation, with diplopia being the most common symptom. At times, painful diplopia is present.

Usually, the patient has a preceding history of cancer. Occasionally, cavernous sinus syndrome is the first manifestation of a systemic neoplasm (leukemia, lymphoma). 

Exophthalmos can be observed.

If the tumor is a pituitary macroadenoma, endocrine symptoms and/or visual field deficits may be present.

Carotid-cavernous aneurysms 

Patients frequently are elderly and present with subacute or chronic ophthalmoplegia. Rarely, they may have pain similar to that of trigeminal neuralgia.

Spontaneous rupture of a carotid-cavernous aneurysm leads to an abrupt onset of a direct carotid-cavernous fistula. This results in the acute onset of massive exophthalmos with orbital, ocular, and conjunctival chemosis, binocular diplopia, and visual loss. 

There are two types of CCFs. Direct fistulas present with prominent acute symptoms. Indirect fistulas are characterized by mild proptosis, chronic diplopia, drooping of the lid, a red eye, arterialization of the conjunctival vessels, and visual loss. The patient may report subjective "noises" in his or her head. 

Cavernous sinus thrombosis 

Cavernous sinus thrombosis (CST) is infrequent in the antibiotic era. It may occur as a complication of spreading infection from the ethmoid, sphenoid, or frontal sinuses or midfacial, dental, or orbital infections. 

Patients may present with sepsis or metastatic spread of septic emboli, most commonly occurring in the lung. This presentation may appear as acute respiratory distress syndrome (ARDS). Other systemic signs of sepsis include chills, fever, shock, delirium, and coma. [5]

Retrobulbar pain, drooping of the upper eyelid, and diplopia may be the first symptoms indicating the lesion's extension to the cavernous sinus. 

Miscellaneous inflammatory lesions 

These may involve the cavernous sinuses or the walls of the sinus.

Herpes zoster in its acute or chronic stage rarely causes pain, diplopia, and a droopy eyelid in addition to the typical zoster blisters. In the chronic stage, a scar from the acute lesion usually is found. 

An idiopathic inflammation of the walls of the cavernous sinuses is referred to as Tolosa-Hunt syndrome.

Sarcoid or Wegener granulomatosis may also predispose to cavernous sinus syndrome.

Physical

Cavernous sinus lesions are characterized by the following signs: 

  • Unilateral and isolated third, fourth, or sixth cranial nerve palsy
  • Variety of combination nerve palsies resulting in partial or complete ophthalmoplegia
  • Painful ophthalmoplegia
  • Proptosis (pulsating exophthalmos suggests a direct CCF)
  • Ocular and cranial bruits
  • Conjunctival congestion; arterialization of conjunctival veins
  • Ocular hypertension
  • Optic disc edema or pallor; retinal hemorrhages
  • Anesthesia in the ophthalmic division of the trigeminal nerve (V1) and/or decreased or absent corneal reflex and possibly anesthesia in the maxillary or V2 branch 
  • Pupil in mid-position and nonreactive if both sympathetic and parasympathetic fibers of the third nerve are affected

Cavernous sinus tumors 

Metastatic lesions: Isolated or combined ophthalmoplegia, painful ophthalmoplegia, anesthesia in the ophthalmic nerve

Pituitary tumors: Isolated or combined ophthalmoplegia (lateral extension); endocrine signs such as acromegaly, gigantism, galactorrhea, Cushing’s disease, and temporal or bitemporal visual field defects 

Primary intracranial tumors: Isolated or combined ophthalmoplegia and/or primary aberrant regeneration of the third cranial nerve

Cavernous sinus aneurysms 

Isolated or combined ophthalmoplegia

Painful ophthalmoplegia

Decreased pain sensation in the V1 ophthalmic division

Carotid-cavernous fistulas 

Direct: Unilateral massive proptosis, pulsating exophthalmos, lid congestion, conjunctival chemosis, orbital congestion, ocular hypertension, visual loss, optic neuropathy, optic disc edema, retinal hemorrhages, retinal venous congestion, loud ocular and cranial bruit

Indirect: Similar signs and symptoms of lesser severity; occasionally, isolated ophthalmoplegia, particularly if the fistula drains posteriorly

Cavernous sinus thrombosis 

Generally speaking, a primary infectious process involving paranasal sinuses and/or orbital cellulitis

In addition to local and systemic signs of infection, the following may be seen: 

  • Isolated or combined ophthalmoplegia
  • Painful ophthalmoplegia
  • Orbital congestion, lid chemosis, proptosis
  • Visual loss, optic disc edema (unilateral)
  • Signs of meningeal irritation

Miscellaneous cavernous sinus lesions 

Tolosa-Hunt syndrome: Isolated or combined, painful ophthalmoplegia

Herpes zoster: Acute zoster ophthalmicus, typical skin lesion, and keratitis

Sarcoidosis: Systemic signs, uveitis, ophthalmoplegia, facial diplegia

Causes

 Metastatic tumors

  • Breast
  • Prostate
  • Lung

Localized spread of tumor 

  • Nasopharyngeal
  • Pituitary

Primary intracranial tumors 

  • Meningiomas
  • Neurofibromas
  • Chondromas (less common)
  • Lymphomas

Trauma (including postsurgical)

  • Carotid-cavernous aneurysms
  • Carotid-cavernous fistulas
  • Cavernous sinus thrombosis

Miscellaneous inflammatory syndromes 

  • Herpes zoster
  • Tolosa-Hunt syndrome
  • Sarcoidosis
  • Tuberculosis
  • Wegener granulomatosis

Diagnostic Workup

Patients in whom cavernous sinus lesions are suspected should undergo thin-section multiplanar imaging studies of the orbit and the sellar/parasellar region. Pre-contrast and postcontrast scans are advisable. CT scan offers better visualization of bone structures. However, MRI using T2, fluid-attenuated inversion recovery (FLAIR), pre-contrast and post-contrast T1-weighted with a fat-saturated protocol image provide better detail of all soft tissues contained in the sinuses, the expected signal void of the carotid artery (image below), and its relation to the surrounding structures as well as individual nerves if the thin-section 3D are acquired.

A T1-weighted, coronal MRI. A T1-weighted, coronal MRI.

Orbital views are necessary to exclude a disease process primarily involving the cavernous sinuses with concomitant compromise of the orbital apex. Conversely, primary orbit and paranasal sinus disorders frequently may involve the cavernous sinuses. Visualization of the superior and inferior orbital veins helps diagnose increased venous pressure. Once imaging is obtained and reviewed in light of clinical findings, further investigation can be pursued to determine a specific diagnosis.

Cavernous sinus tumors

In the case of metastatic tumors, diagnosis of the primary neoplasm generally precedes the cavernous sinus syndrome.

A lumbar puncture with cytologic examination can be helpful.

If a primary neoplasm of the nasopharynx is suspected, a biopsy may be needed.

In the case of pituitary tumors with lateral extension, tumor resection may be necessary.

Rarely, a biopsy of the cavernous sinus tumor is needed for diagnosis.

Cavernous sinus aneurysms

As MRI and/or magnetic resonance angiography (MRA) are often specific, cerebral angiography generally is not required to make a diagnosis. 

Perform arteriography if endovascular occlusion of the aneurysm or fistula is planned.

Carotid-cavernous fistulas

Digital subtraction angiography (DSA) is the gold standard for diagnosis, however, when compared with angiography, CT and MRI have a much lower incidence of complications. [6, 7] Furthermore, CT and MRI scans depict peripheral pathologies associated with CCFs (eg, enlargement of cavernous sinus and the ophthalmic vein). Angiography is used to confirm CT or MRI findings before treatment.

CT findings may be sufficient for diagnosis in most patients although MRI and angiography are superior in evaluating venous distention, the aneurysm lumen, and the increased flow to the cavernous sinus.

The dramatic clinical presentation and MRI and/or MRA of direct fistulas leave little doubt regarding the diagnosis. A study of 98 suspected cases of CCF evaluated with thin-section MR imaging reported overall accuracy, sensitivity, and specificity of 88.8%, 97.4%, and 83.3%, respectively. Abnormal contour of the cavernous sinus, internal signal void of the cavernous sinus, prominent venous drainage flow, and orbital/periorbital soft tissue swelling were proposed as possible predictive findings. [8]

By contrast, indirect fistulas, particularly those draining into the petrosal sinuses, are associated with subtle findings and possibly a normal MRI and/or MRA (images below). 

This patient is a 55-year-old woman who originallyThis patient is a 55-year-old woman who originally had symptoms of eye pain and pulse synchronous tinnitus on the left. She was found to have an indirect left carotid cavernous sinus fistula and underwent successful coiling of the fistula. This picture shows her after the procedure, as she had developed left eye chemosis and diplopia. A left lateral rectus paralysis was present on examination. In this case, the probable causes of the ophthalmoplegia could be mass effect or occlusion of the vasa nervorum supplying the sixth cranial nerve, which travels in the adventitia of the carotid artery. Here, the prognosis is excellent, and the authors have seen several cases with improvement within 4-8 weeks after coiling.
Early phase of the post-fistula coiling angiogram Early phase of the post-fistula coiling angiogram of the patient shown above. Coils can be appreciated at the cavernous portion of the carotid artery.
Later filling phase of the angiogram for the patieLater filling phase of the angiogram for the patient shown above. Note that coiling has prevented anomalous filling of the cavernous sinus fistula.

Cerebral angiography is the only way to arrive at the correct diagnosis. Perform angiography to stage the fistula and document the anterior and posterior drainage routes.

Cavernous sinus thrombosis

Imaging the orbit and/or nasal sinuses is helpful in the search for an infectious/inflammatory source. Historically, several techniques have been used to image, including plain sinus radiography, carotid angiography, and orbital venography. In current practice, computed tomography (CT) scan or magnetic resonance imaging (MRI) with contrast is the modality of choice to confirm the diagnosis of CST and to differentiate it from alternatives such as orbital cellulitis, which may have a similar clinical presentation. [9]

An aseptic thrombosis may be associated with conditions such as hyper-coagulopathy and lymphoproliferative disorders.

A hematologic workup is indicated in these patients.

Miscellaneous inflammatory syndromes

Other systemic inflammatory and granulomatous processes require investigation after more common causes have been excluded. These disorders can be screened by additional laboratory tests and chest radiograms.

Tolosa-Hunt syndrome (an uncommon, idiopathic, inflammatory cavernous sinus syndrome) shares a close etiologic link with orbital pseudotumor. 

A nonspecific fibrotic inflammatory reaction and rarely a granulomatous inflammation can occur, but biopsy is seldom used to establish the diagnosis. 

A positive response to steroids is considered diagnostic, but false-positive responses can occur in lymphoma and other parasellar neoplasms. 

Biopsy of the cavernous sinuses entails a craniotomy, which is associated with morbidity. Restrict a craniotomy to patients with a documented, progressive cavernous sinus syndrome. 

Treatment and Management

Cavernous sinus tumors

Metastatic lesions 

  • Radiotherapy may offer transient improvement

  • Nasopharyngeal carcinomas may be very radiosensitive, with a prolonged remission following treatment

  • Pituitary tumors 

  • Prolactinomas may improve with oral dopamine agonists, or they may require resection

  • Gamma knife may be an adjunctive treatment for postoperative tumor residual or recurrent tumor, and it may have a role as an alternative to open surgical treatment

Cavernous sinus meningiomas 

  • These lesions represent a major challenge for surgical resection, primarily because of poor accessibility and the frequent encasement of the cavernous carotid artery. 

  • Since these tumors are slow-growing and difficult to resect, elderly patients or those with minor symptoms probably should be observed expectantly without specific treatment. 

  • Radiotherapy may be offered to some patients, and some show improvement in cranial nerve function after gamma knife treatment. Partial resection may be attempted in others with disabling symptoms (eg, intractable pain, total ophthalmoplegia in a patient with poor vision in the nonparetic eye). 

Cavernous sinus aneurysms

Treat cavernous sinus aneurysms by endovascular balloon occlusion.

Carotid-cavernous fistulas

Treatment ideally consists of endovascular obliteration of the fistula with coils, although some cavernous sinus dural arteriovenous fistulas may be managed observationally. 

Access to the fistula may be intraarterial; however, the transvenous approach has become the mainstay of treatment, in some cases a combined surgical/endovascular approach can be used with surgical exposure of the superior ophthalmic vein followed by fistula embolization. Several venous approaches have been used, including the safest transfemoral approach; however, if this is not feasible, a superior orbital vein or a percutaneous trans-orbital puncture to the cavernous sinus can be used. [10]  

Supraorbital vein dissection with the placement of a catheter to access the cavernous sinuses has been performed successfully.

Percutaneous trans-orbital access to the cavernous sinus followed by embolization.

Small indirect CCFs may occlude either spontaneously or following diagnostic angiography. If the clinical signs are mild, consider careful monitoring. 

If intraocular pressure is elevated, antiglaucoma agents may be required.

Cavernous sinus thrombosis

High-dose antibiotic therapy should be directed against the most common pathogens, such as S. aureus and S. pneumoniae, as well as gram-negative rods and anaerobes.

Anticoagulation in cavernous sinus thrombosis evoked by infection is controversial but may hasten recovery.

Drainage of any primary site of infection (eg, abscess, sinusitis) is advised.

Corticosteroids are not recommended.

Anticoagulation also may be helpful in aseptic patients.

Miscellaneous inflammatory syndromes

Inflammatory cavernous sinus syndromes may respond to treatment of the specific systemic inflammation or vasculitis.

Tolosa-Hunt syndrome responds well to a 3- to 6-month course of high-dose steroid therapy that can be slowly tapered.

Previous
TOP PICKS FOR YOU
Medscape

Log in or register for free to unlock more Medscape content

Unlimited access to our entire network of sites and services